Abstract
The treatment of rheumatoid arthritis is challenging because of the diversity of disease courses (from mild to aggressive) and because of the large varying response to treatment. At present, the individual patient is treated in accordance to international guidelines based on findings from randomized controlled trials and large study cohorts. As a consequence, each patient does not get the optimal treatment from his/her individual perspective. In this article the currently available ways that could optimize the treatment in the individual patient are addressed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
